Search results
Found 547 matches for
We are excited to announce that one of our resident companies, Base Genomics, has been acquired by Exact Sciences for $410 million. The acquisition will undoubtedly further propel Base Genomics' groundbreaking technology alongside Exact Sciences' existing expertise, ultimately enhancing cancer diagnostics.
